Bellemin Jean-Marc 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Bellemin Jean-Marc
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-03-01+105,470→ 105,470 total→ Common stock (105,470 underlying) - Award
Restricted Stock Units
2024-03-01+46,875→ 46,875 total→ Common stock (46,875 underlying)
Footnotes (3)
- [F1]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
- [F3]50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant.